Having won US Food & Drug Administration approval for its nerve repair agent Remplir, Orthocell is wasting no time getting it ...

ASX takes a beating as US-China trade war escalates, but biotech and rare earth stocks shine despite uncertain market ...

With critical minerals becoming ever more important, Saskatchewan has all the right ingredients to be a major player.

A price turnaround and the prospect of accelerated rate cuts puts residential property back in favour as share markets turn ...

Firetail Resources (ASX:FTL) moves to refine porphyry potential at Picha project with field programs and geophysics ...

A big mover among small caps was Leeuwin Metals after a review of drilling at Marda gold project pointed to extensive mineralisation.

Donald Trump has flagged a tariff on the pharmaceutical sector, which to date has been on the exempt goods list.

GTI Energy (ASX:GTR) is nearing completion of its interim scoping study at the Lo Herma in situ recovery uranium project in Wyoming.

ASX cops a beating as the US-China trade spat rocks markets, pharma faces tariff pain, oil dives, and Aussie miners take a hit.

Tony Locantro takes in the shockwaves of the Trump tariffs and goes into how he plans on navigating through the chaos.

Maronan’s (ASX:MMA) high-grade copper-gold results in the shallow Starter Zone could present early mining options for its namesake project.

Trump's 'Liberation Day' movement has hammered equities, but these ASX stocks are positioning for a US manufacturing boom.